News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Clinical, In the Media, Research
Rising WashU Medicine Physician-Scientist Researches Ways to Prevent Recurrence in AML
Francesca Ferraro receives Damon Runyon Clinical Investigator Award for her acute myeloid leukemia work Francesca Ferraro, MD, PhD, a WashU Medicine researcher and medical oncologist at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has been named a 2026 Damon Runyon Clinical Investigator Award. The grant, given by the Damon Runyon Cancer Research Foundation, supports early-career […]
Clinical, In the Media, Research
WashU Medicine Researchers at Siteman Earn National Recognition for Leukemia Research
American Society of Hematology awards grants to Francesca Ferraro, Jaebok Choi Two WashU Medicine investigators at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, have been awarded prestigious grants from the American Society of Hematology (ASH), the world’s largest professional society serving clinicians and scientists working to conquer blood diseases. Francesca Ferraro, MD, […]
Clinical, In the Media, Research
Jessica Silva-Fisher Receives American Cancer Society Grant
WashU Medicine investigator at Siteman Cancer Center aims to study how chemical modifications to RNA contribute to the progression of multiple myeloma Jessica Silva-Fisher, PhD, a WashU Medicine scientist at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has received a Research Scholar Grant from the American Cancer Society (ACS) — one of only […]
Health & Wellness, In the Media, Patient Resource, Prevention
For Your Health — What to Know About Dementia — and Ways to Prevent It
Dementia touches many lives — in many different ways. And most of us likely have some firsthand experience with it, whether it’s with an aging family member or friend or neighbor. Over 6 million people in the U.S. have some type of dementia, and these numbers are expected to accelerate in the coming years as […]
Clinical, In the Media, Research
Newly Approved Pancreatic Cancer Treatment Has Been Shown To Prolong Life — And Highlights Siteman’s Role in Bringing Innovation to Patients
FDA approves first-in-class drug trialed at WashU Medicine and Siteman Cancer Center — a new option for patients with metastatic disease Daraxonrasib is a drug that targets RAS proteins, which are mutated in more than 90% of pancreatic cancers. As a clinical trial site, Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine evaluated the […]
Staff/Faculty Update
Hall Recognized for Prostate Cancer Care, Compassion
Lannis Hall, MD, MPH, a professor of clinical radiation oncology at WashU Medicine and medical director of radiation oncologist at Siteman Cancer Center at Barnes-Jewish St. Peters Hospital, has been honored with the 2026 Guardian Angel Award: Wind Beneath Our Wings by The Empowerment Network, a nonprofit dedicated to patient advocacy, support and education. The award recognizes Hall’s impact […]
Educational
Technique Evaluates Reliability of Imaging Measurements Used in Medical Decision-Making
Method could help clinicians, regulators assess new wave of AI-enabled quantitative imaging products Advances in medical imaging and artificial intelligence (AI) have revolutionized many aspects of medical practice in recent years. Quantitative measurements derived from medical images are increasingly being used to support diagnosis and clinical decision-making. Consequently, many new quantitative imaging tools, including those […]
Clinical, Research
mRNA-Based Therapy Offers New Hope Against High-Risk Melanoma
Siteman Cancer Center served as a major, early clinical trial site for groundbreaking vaccine In a major announcement, an experimental mRNA vaccine has been shown in global clinical trials to prevent melanoma from returning or spreading in high-risk melanoma patients when combined with the immunotherapy drug pembrolizumab, known commercially as Keytruda, and given after surgery. The […]
Research
New Discovery May Point to Clues About How Head and Neck Cancers Spread
WashU Medicine researchers at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, along with colleagues at the Weizmann Institute of Science in Israel, have found that aggressive cancer cells can appear in different locations within head and neck tumors, providing new clues as to why some such cancers — particularly squamous cell carcinomas not caused by […]
In the Media, Research
Laser Therapy Offers Weapon Against Deadly Brain Tumors
Large analysis of patient outcomes shows that extent of tumor ablation, treatment timing extends survival For patients facing a diagnosis of glioblastoma — one of the most aggressive and devastating forms of brain cancer — the standard path forward has long meant an invasive open-skull surgery and a daunting prognosis. Over the past decade and […]